Cited by 102Sleep and Wakefulness ResearchMemory and Neural MechanismsNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 100 of the 101 references it cites were found in a registry or an index.

Orexins and fear: implications for the treatment of anxiety disorders

Flores, África, Saravia, Rocío, Maldonado, Rafael, Berrendero, Fernando·2015·Trends in Neurosciences

DOI 10.1016/j.tins.2015.06.005

Open this paper in CoChat — free account

Abstract

An understanding of the neurobiological mechanisms involved in the regulation of fear is essential for the development of new treatments for anxiety disorders, such as phobias, panic, and post-traumatic stress disorders (PTSD). Orexins, also known as hypocretins, are neuropeptides located exclusively in hypothalamic neurons that have extensive projections throughout the central nervous system. Although this system was initially believed to be primarily involved in the regulation of feeding behavior, recent studies have shown that orexins also modulate neural circuits implicated in the expression and extinction of fear memories. Here, we discuss recent findings involving orexins in anxiety disorders and current clinical trials using orexin ligands that could be applied to identify new therapies for diseases characterized by pathological fear.

Integrity signals

Registry

Crossref · 10.1016/j.tins.2015.06.005

Cites

100 of 100 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Emotion circuits in the brain
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior
Sakurai, T., Amemiya, A., Ishii, M., Matsuzaki, I., Chemelli, R. M., Tanaka, H., Williams, S. C., Richardson, J. A., Kozlowski, G. P., Wilson, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80949-6 · Cited by 5,501
The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity
de Lecea, L., Kilduff, T. S., Peyron, C., Gao, X.-B., Foye, P. E., Danielson, P. E., Fukuhara, C., Battenberg, E. L. F., Gautvik, V. T., Bartlett, F. S., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.322 · Cited by 3,878
The size and burden of mental disorders and other disorders of the brain in Europe 2010
Wittchen, H. U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jönsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., et al. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.018 · Cited by 3,754
Neurons containing hypocretin (orexin) project to multiple neuronal systems
Peyron, C., Tighe, D. K., van den Pol, A. N., de Lecea, L., Heller, H. C., Sutcliffe, J. G., & Kilduff, T. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09996.1998 · Cited by 3,466
Narcolepsy in orexin Knockout Mice
Chemelli, R. M., Willie, J. T., Sinton, C. M., Elmquist, J. K., Scammell, T., Lee, C., Richardson, J. A., Williams, S. C., Xiong, Y., Kisanuki, Y., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81973-x · Cited by 3,095
Twelve‐month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States
Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. (2012) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1359 · Cited by 2,947
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
Lin, L., Faraco, J., Li, R., Kadotani, H., Rogers, W., Lin, X., Qiu, X., de Jong, P. J., Nishino, S., & Mignot, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81965-0 · Cited by 2,613
A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains
Peyron, C., Faraco, J., Rogers, W., Ripley, B., Overeem, S., Charnay, Y., Nevsimalova, S., Aldrich, M., Reynolds, D., Albin, R., et al. (2000) · Nature Medicine · doi:10.1038/79690 · Cited by 2,118
Differential expression of orexin receptors 1 and 2 in the rat brain
Marcus, J. N., Aschkenasi, C. J., Lee, C. E., Chemelli, R. M., Saper, C. B., Yanagisawa, M., & Elmquist, J. K. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1190 · Cited by 1,659
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
The contextual brain: implications for fear conditioning, extinction and psychopathology
Maren, S., Phan, K. L., & Liberzon, I. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3492 · Cited by 1,547
Neural substrates of awakening probed with optogenetic control of hypocretin neurons
Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K., & de Lecea, L. (2007) · Nature · doi:10.1038/nature06310 · Cited by 1,341
Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear
Sierra-Mercado, D., Padilla-Coreano, N., & Quirk, G. J. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.184 · Cited by 1,190
Reciprocal Connections between the Amygdala and the Hippocampal Formation, Perirhinal Cortex, and Postrhinal Cortex in Rat: A Review
Pitkänen, A., Pikkarainen, M., Nurminen, N., & Ylinen, A. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06738.x · Cited by 1,001
Hypothalamic Orexin Neurons Regulate Arousal According to Energy Balance in Mice
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., Tominaga, M., Yagami, K.-I., Sugiyama, F., Goto, K., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00331-3 · Cited by 958
Switching on and off fear by distinct neuronal circuits
Herry, C., Ciocchi, S., Senn, V., Demmou, L., Müller, C., & Lüthi, A. (2008) · Nature · doi:10.1038/nature07166 · Cited by 950
Afferents to the orexin neurons of the rat brain
Yoshida-Court, K., McCormack, S. L., España, R. A., Crocker, A. J., & Scammell, T. E. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20859 · Cited by 592
Direct Involvement of Orexinergic Systems in the Activation of the Mesolimbic Dopamine Pathway and Related Behaviors Induced by Morphine
Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., Sakurai, T., Yanagisawa, M., Nakamachi, T., Shioda, S., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.2761-05.2006 · Cited by 524
Prefrontal parvalbumin interneurons shape neuronal activity to drive fear expression
Courtin, J., Chaudun, F., Rozeske, R. R., Karalis, N., Gonzalez-Campo, C., Wurtz, H., Abdi, A., Baufreton, J., Bienvenu, T. C. M., & Herry, C. (2014) · Nature · doi:10.1038/nature12755 · Cited by 524
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
Michelson, D., Snyder, E., Paradis, E. M., Chengan-Liu, M., Snavely, D. B., Hutzelmann, J., Walsh, J. K., Krystal, A. D., Benca, R. M., Cohn, M. A., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70053-5 · Cited by 520
The paraventricular thalamus controls a central amygdala fear circuit
Penzo, M. A., Robert, V., Tucciarone, J., De Bundel, D., Wang, M., Van Aelst, L., Darvas, M., Parada, L. F., Palmiter, R. D., He, M., et al. (2015) · Nature · doi:10.1038/nature13978 · Cited by 506
Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma
Vaiva, G., Ducrocq, F., Jezequel, K., Averland, B., Lestavel, P., Brunet, A., & Marmar, C. R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00412-8 · Cited by 499
A temporal shift in the circuits mediating retrieval of fear memory
Do-Monte, F. H., Quiñones-Laracuente, K., & Quirk, G. J. (2015) · Nature · doi:10.1038/nature14030 · Cited by 491
The role of orexin in motivated behaviours
Sakurai, T. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3837 · Cited by 478
Input of Orexin/Hypocretin Neurons Revealed by a Genetically Encoded Tracer in Mice
Sakurai, T., Nagata, R., Yamanaka, A., Kawamura, H., Tsujino, N., Muraki, Y., Kageyama, H., Kunita, S., Takahashi, S., Goto, K., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.03.010 · Cited by 468
Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response
Winsky-Sommerer, R., Yamanaka, A., Diano, S., Borok, E., Roberts, A. J., Sakurai, T., Kilduff, T. S., Horvath, T. L., & de Lecea, L. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3459-04.2004 · Cited by 462
Neural and cellular mechanisms of fear and extinction memory formation
Orsini, C. A., & Maren, S. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.12.014 · Cited by 429
A key role for orexin in panic anxiety
Johnson, P. L., Truitt, W. A., Fitz, S. D., Minick, P. E., Dietrich, A. D., Sanghani, S. P., Träskman‐Bendz, L., Goddard, A. W., Brundin, L., & Shekhar, A. (2009) · Nature Medicine · doi:10.1038/nm.2075 · Cited by 429
Motivational activation: a unifying hypothesis of orexin/hypocretin function
Mahler, S. V., Moorman, D. E., Smith, R. J., James, M. H., & Aston‐Jones, G. (2014) · Nature Neuroscience · doi:10.1038/nn.3810 · Cited by 392
The Study of Fear Extinction: Implications for Anxiety Disorders
Graham, B. M., & Milad, M. R. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11040557 · Cited by 387
Discovery of the Dual Orexin Receptor Antagonist [(7 R )-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2 H -1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Cox, C. D., Breslin, M. J., Whitman, D. B., Schreier, J. D., McGaughey, G. B., Bogusky, M. J., Roecker, A. J., Mercer, S. P., Bednar, R. A., Lemaire, W., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100541c · Cited by 381
An Inhibitory Interface Gates Impulse Traffic between the Input and Output Stations of the Amygdala
Royer, S., Martina, M., & Paré, D. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-23-10575.1999 · Cited by 350
A selective orexin-1 receptor antagonist reduces food consumption in male and female rats
Haynes, A. C., Jackson, B., Chapman, H., Tadayyon, M., Johns, A., Porter, R. A., & Arch, J. R. S. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00199-3 · Cited by 338
Attenuated defense response and low basal blood pressure in orexin knockout mice
Kayaba, Y., Nakamura, A., Kasuya, Y., Ohuchi, T., Yanagisawa, M., Komuro, I., Fukuda, Y., & Kuwaki, T. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00671.2002 · Cited by 337
Role of lateral hypothalamic orexin neurons in reward processing and addiction
Aston‐Jones, G., Smith, R. J., Moorman, D. E., & Richardson, K. A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.060 · Cited by 335
Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray
Johansen, J. P., Tarpley, J. W., LeDoux, J. E., & Blair, H. T. (2010) · Nature Neuroscience · doi:10.1038/nn.2594 · Cited by 312
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials
Herring, W. J., Connor, K. M., Ivgy-May, N., Snyder, E., Liu, K., Snavely, D. B., Krystal, A. D., Walsh, J. K., Benca, R. M., Rosenberg, R. P., et al. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.10.003 · Cited by 300
Projections of the paraventricular and paratenial nuclei of the dorsal midline thalamus in the rat
Vertes, R. P., & Hoover, W. B. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21679 · Cited by 296
Context representations, context functions, and the parahippocampal–hippocampal system
Rudy, J. W. (2009) · Learning & Memory · doi:10.1101/lm.1494409 · Cited by 296
Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects
Salomon, R. M., Ripley, B. A., Kennedy, J. S., Johnson, B. W., Schmidt, D. E., Zeitzer, J. M., Nishino, S., & Mignot, E. J.-M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01740-7 · Cited by 288
Impaired Fear Extinction Learning and Cortico-Amygdala Circuit Abnormalities in a Common Genetic Mouse Strain
Hefner, K. R., Whittle, N., Juhasz, J., Norcross, M. A., Karlsson, R., Saksida, L. M., Bussey, T. J., Singewald, N., & Holmes, A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4904-07.2008 · Cited by 256
The hypocretins/orexins: integrators of multiple physiological functions
Li, J., Hu, Z., & de Lecea, L. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12415 · Cited by 253
Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction
Blouin, A. M., Fried, I., Wilson, C. L., Staba, R. J., Behnke, E., Lam, H. A., Maidment, N. T., Karlsson, K. Æ., Lapierre, J. L., & Siegel, J. M. (2013) · Nature Communications · doi:10.1038/ncomms2461 · Cited by 251
Orexin, stress, and anxiety/panic states
Johnson, P. L., Molosh, A. I., Fitz, S. D., Truitt, W. A., & Shekhar, A. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59489-1.00009-4 · Cited by 227
Orexin/hypocretin system modulates amygdala-dependent threat learning through the locus coeruleus
Sears, R. M., Fink, A. E., Wigestrand, M. B., Farb, C. R., de Lecea, L., & LeDoux, J. E. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1320325110 · Cited by 226
Orexin/hypocretin receptor signalling cascades
Kukkonen, J. P., & Leonard, C. S. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12324 · Cited by 213
Bidirectional synaptic plasticity in intercalated amygdala neurons and the extinction of conditioned fear responses
Royer, S., & Paré, D. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00455-4 · Cited by 210
Resistance to extinction is associated with impaired immediate early gene induction in medial prefrontal cortex and amygdala
Herry, C., & Mons, N. E. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03542.x · Cited by 192
Orexins in the paraventricular nucleus of the thalamus mediate anxiety-like responses in rats
Li, Y., Li, S., Wei, C., Wang, H., Sui, N., & Kirouac, G. J. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1948-y · Cited by 184
Hypocretin/orexin in arousal and stress
Berridge, C. W., España, R. A., & Vittoz, N. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.09.019 · Cited by 180
Hypocretin 1/orexin A in the ventral tegmental area enhances dopamine responses to cocaine and promotes cocaine self-administration
España, R. A., Melchior, J. R., Roberts, D. C. S., & Jones, S. R. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2048-8 · Cited by 175
Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior
Suzuki, M., Beuckmann, C. T., Shikata, K., Ogura, H., & Sawai, T. (2005) · Brain Research · doi:10.1016/j.brainres.2005.03.002 · Cited by 161
Orexin (hypocretin) innervation of the paraventricular nucleus of the thalamus
Kirouac, G. J., Parsons, M. P., & Li, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.035 · Cited by 157
Individual differences in recovery from traumatic fear
Holmes, A., & Singewald, N. (2012) · Trends in Neurosciences · doi:10.1016/j.tins.2012.11.003 · Cited by 147
The Hypocretin/Orexin System Mediates the Extinction of Fear Memories
Flores, Á., Valls-Comamala, V., Costa, G., Saravia, R., Maldonado, R. J., & Berrendero, F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.146 · Cited by 134
Self-citation
Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical Trial
Hoever, P., Dorffner, G., Beneš, H., Penzel, T., Danker‐Hopfe, H., Barbanoj, M. J., Pillar, G., Saletu, B., Polo, O. J., Kunz, D., et al. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.370 · Cited by 125
Orexin Receptor-1 in the Locus Coeruleus Plays an Important Role in Cue-Dependent Fear Memory Consolidation
Soya, S., Shoji, H., Hasegawa, E., Hondo, M., Miyakawa, T., Yanagisawa, M., Mieda, M., & Sakurai, T. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1130-13.2013 · Cited by 124
Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis
Chabi, A., Zhang, Y., Jackson, S., Cady, R. K., Lines, C., Herring, W. J., Connor, K. M., & Michelson, D. (2014) · Cephalalgia · doi:10.1177/0333102414544979 · Cited by 123
Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?
Hoyer, D., & Jacobson, L. H. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.009 · Cited by 109
Is it Beneficial to Add Pharmacotherapy to Cognitive-Behavioral Therapy When Treating Anxiety Disorders? A Meta-Analytic Review
Hofmann, S. G., Sawyer, A. T., Korte, K. J., & Smits, J. A. J. (2009) · International Journal of Cognitive Therapy · doi:10.1521/ijct.2009.2.2.160 · Cited by 109
Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder
Strawn, J. R., Pyne‐Geithman, G. J., Ekhator, N. N., Horn, P. S., Uhde, T. W., Shutter, L., Baker, D. G., & Geracioti, T. D. (2010) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.01.001 · Cited by 109
Medial Prefrontal Cortex
Maroun, M. (2012) · The Neuroscientist · doi:10.1177/1073858412464527 · Cited by 107
Hypocretin (orexin) neuromodulation of stress and reward pathways
Giardino, W. J., & de Lecea, L. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.07.006 · Cited by 105
Genetic Strain Differences in Learned Fear Inhibition Associated with Variation in Neuroendocrine, Autonomic, and Amygdala Dendritic Phenotypes
Camp, M., MacPherson, K. P., Lederle, L. I., Graybeal, C., Gaburro, S., DeBrouse, L., Ihne, J. L., Bravo, J. A., O’Connor, R. M., Ciocchi, S., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.340 · Cited by 103
Activation of the orexin 1 receptor is a critical component of CO2-mediated anxiety and hypertension but not bradycardia
Johnson, P. L., Samuels, B. C., Fitz, S. D., Lightman, S. L., Lowry, C. A., & Shekhar, A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.38 · Cited by 101
Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats
Brown, R. M., Khoo, S. Y.-S., & Lawrence, A. J. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000333 · Cited by 101
A Selective Orexin-1 Receptor Antagonist Attenuates Stress-Induced Hyperarousal without Hypnotic Effects
Bonaventure, P., Yun, S., Johnson, P. L., Shekhar, A., Fitz, S. D., Shireman, B. T., Lebold, T. P., Nepomuceno, D. H., Lord, B., Wennerholm, M. L., et al. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.220392 · Cited by 101
A time-dependent role of midline thalamic nuclei in the retrieval of fear memory
Padilla-Coreano, N., Do-Monte, F. H., & Quirk, G. J. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.037 · Cited by 100
Reduced amygdala activity during aversive conditioning in human narcolepsy
Ponz, A., Khatami, R., Poryazova, R., Werth, E., Boesiger, P., Schwartz, S., & Bassetti, C. L. (2009) · Annals of Neurology · doi:10.1002/ana.21881 · Cited by 95
Respiration and autonomic regulation and orexin
Nattie, E., & Li, A. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59489-1.00004-5 · Cited by 90
Panic-Prone State Induced in Rats with GABA Dysfunction in the Dorsomedial Hypothalamus Is Mediated by NMDA Receptors
Johnson, P. L., & Shekhar, A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0408-06.2006 · Cited by 89
Epigenetic mechanisms in fear conditioning: Implications for treating post-traumatic stress disorder
Kwapis, J. L., & Wood, M. A. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.005 · Cited by 87
The Hypocretin/Orexin System: An Increasingly Important Role in Neuropsychiatry
Chen, Q., de Lecea, L., Hu, Z., & Gao, D. (2014) · Medicinal Research Reviews · doi:10.1002/med.21326 · Cited by 86
The orexin antagonist SB-649868 promotes and maintains sleep in men with primary insomnia.
Bettica, P., Squassante, L., Zamuner, S., Nucci, G., Danker-Hopfe, H., & Ratti, E. (2012) · Sleep · doi:10.5665/sleep.1996 · Cited by 86
Regulatory Mechanisms of Fear Extinction and Depression-Like Behavior
Tronson, N. C., Schrick, C., Fischer, A., Sananbenesi, F., Pagès, G., Pouysségur, J., & Radulović, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301550 · Cited by 86
Neuronal correlates of fear conditioning in the bed nucleus of the stria terminalisPreprint
Haufler, D., Nagy, F. Z., & Paré, D. (2013) · Learning & Memory · doi:10.1101/lm.031799.113 · Cited by 81
The brain orexin system and almorexant in fear-conditioned startle reactions in the rat
Steiner, M. A., Lecourt, H., & Jenck, F. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2736-7 · Cited by 80
Hypocretin receptor 2 antagonism dose-dependently reduces escalated heroin self-administration in rats
Schmeichel, B. E., Barbier, E., Misra, K. K., Contet, C., Schlosburg, J. E., Grigoriadis, D., Williams, J. P., Karlsson, C., Pitcairn, C., Heilig, M., et al. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.293 · Cited by 79
Neural Pathways Underlying Lactate-Induced Panic
Johnson, P. L., Truitt, W. A., Fitz, S. D., Lowry, C. A., & Shekhar, A. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301621 · Cited by 78
Lesions of the posterior paraventricular nucleus of the thalamus attenuate fear expression
Li, Y., Dong, X., Li, S., & Kirouac, G. J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00094 · Cited by 76
Review: Acids in the brain: a factor in panic?
Esquivel, G., Schruers, K. R. J., Maddock, R., Colasanti, A., & Griez, E. J. L. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109104847 · Cited by 75
Cannabinoid-hypocretin cross-talk in the central nervous system: what we know so far
Flores, Á., Maldonado, R. J., & Berrendero, F. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00256 · Cited by 74
Self-citation
Optogenetic examination identifies a context-specific role for orexins/hypocretins in anxiety-related behavior
Heydendael, W., Sengupta, A., Beck, S. G., & Bhatnagar, S. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.10.005 · Cited by 73
The MAP(K) of fear: From memory consolidation to memory extinction
Cestari, V., Rossi‐Arnaud, C., Saraulli, D., & Costanzi, M. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.09.007 · Cited by 62
Orexin/Hypocretin Based Pharmacotherapies for the Treatment of Addiction: DORA or SORA?
Khoo, S. Y., & Brown, R. M. (2014) · CNS Drugs · doi:10.1007/s40263-014-0179-x · Cited by 62
The independent predictive value of peritraumatic dissociation for postdisaster intrusions, avoidance reactions, and PTSD symptom severity: A 4-year prospective study
van der Velden, P. G., Kleber, R. J., Christiaanse, B., Gersons, B. P. R., Marcelissen, F., Drogendijk, A. N., Grievink, L., Olff, M., & Meewisse, M. L. (2006) · Journal of Traumatic Stress · doi:10.1002/jts.20140 · Cited by 60
Conditioned‐fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei
Ishida, Y., Hashiguchi, H., Takeda, R., Ishizuka, Y., Mitsuyama, Y., Kannan, H., Nishimori, T., & Nakahara, D. (2002) · Synapse · doi:10.1002/syn.10086 · Cited by 59
Dynorphins Regulate Fear Memory: from Mice to Men
Bilkei‐Gorzó, A., Erk, S., Schurmann, B., Mauer, D., Michel, K., Boecker, H., Scheef, L., Walter, H., & Zimmer, A. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1034-12.2012 · Cited by 59
The Hypocretin/Orexin System: Implications for Drug Reward and Relapse
Plaza‐Zabala, A., Maldonado, R. J., & Berrendero, F. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8255-z · Cited by 58
Self-citation
Orexins (hypocretins) contribute to fear and avoidance in rats exposed to a single episode of footshocks
Chen, X., Wang, H., Zhang, L., Li, S., Li, Y., Bergen, H., Vrontakis, M. E., & Kirouac, G. J. (2013) · Brain Structure and Function · doi:10.1007/s00429-013-0626-3 · Cited by 58
An animal model of panic vulnerability with chronic disinhibition of the dorsomedial/perifornical hypothalamus
Johnson, P. L., & Shekhar, A. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.016 · Cited by 50
Amygdala dysfunction in narcolepsy‐cataplexy
Khatami, R., BIRKMANN, S., & Bassetti, C. L. (2007) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2007.00587.x · Cited by 47
Panic disorder is associated with the Val308Iso polymorphism in the hypocretin receptor gene
Annerbrink, K., Westberg, L., Olsson, M., Andersch, S., Sjödin, I., Holm, G., Allgulander, C., & Eriksson, E. (2010) · Psychiatric Genetics · doi:10.1097/ypg.0b013e328341a3db · Cited by 41
Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Uslaner, J. M., Winrow, C. J., Gotter, A. L., Roecker, A. J., Coleman, P. J., Hutson, P. H., Lê, A. D., & Renger, J. J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.012 · Cited by 35
Orexin‐A and respiration in a rat model of smoke‐induced chronic obstructive pulmonary disease
Liu, Z. L., Song, N., Geng, W., Jin, W., Li, L., Cao, Y., Qian, Y., Zhu, D., & Shen, L. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05411.x · Cited by 32
Orexin neuropeptides contribute to the development and persistence of generalized avoidance behavior in the rat
Viviani, D., Haegler, P., Jenck, F., & Steiner, M. A. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3769-x · Cited by 28
Entry‐into‐humans study with ACT‐462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
Hoch, M., van Gorsel, H. C., van Gerven, J., & Dingemanse, J. (2014) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.297 · Cited by 27
Plasma Orexin-A Levels in COPD Patients with Hypercapnic Respiratory Failure
Zhu, L.-Y., Summah, H. D., Jiang, H., & Qu, J. (2011) · Mediators of Inflammation · doi:10.1155/2011/754847 · Cited by 18

Sorted by citations

Inhibition in the amygdala anxiety circuitry
Babaev, O., Chatain, C. P., & Krueger‐Burg, D. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0063-8 · Cited by 334
Hubs and spokes of the lateral hypothalamus: cell types, circuits and behaviour
Bonnavion, P., Mickelsen, L. E., Fujita, A., de Lecea, L., & Jackson, A. C. (2016) · The Journal of Physiology · doi:10.1113/jp271946 · Cited by 271
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
The Brainstem in Emotion: A Review
Venkatraman, A., Edlow, B. L., & Immordino‐Yang, M. H. (2017) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2017.00015 · Cited by 238
The stressed synapse 2.0: pathophysiological mechanisms in stress-related neuropsychiatric disorders
Sanacora, G., Yan, Z., & Popoli, M. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00540-x · Cited by 197

See all 102

Authors: Flores, Á., Saravia, R., Maldonado, R., & Berrendero, F.
Affiliations: Universitat Pompeu Fabra (ES)
ORCID: Flores, África
Maldonado, Rafael
Berrendero, Fernando
Venue: Trends in Neurosciences
Publisher: Elsevier BV
Published: 2015-09
Volume: 38
Issue: 9
Pages: 550-559
ISSN: 0166-2236 (ISSN-L)
DOI: 10.1016/j.tins.2015.06.005
OpenAlex: W1696117693
Cited by: 102
References: 101
Citations by year: 2026: 4 · 2025: 11 · 2024: 4 · 2023: 8 · 2022: 12 · 2021: 9 · 2020: 14 · 2019: 10 · 2018: 15 · 2017: 9 · 2016: 6
FWCI: 0.98
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Neurosciences (publishedVersion)
PubMed (publishedVersion)
Repositori digital de la UPF (Universitat Pompeu Fabra) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
Life Sciences › Neuroscience › Cognitive Neuroscience › Memory and Neural Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: orexin, fear regulation, anxiety disorders, fear extinction, phobia, panic disorder, post-traumatic stress disorder, hypothalamus
MeSH terms: Orexins, Animals, Anxiety Disorders, Brain, Fear, Humans

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Orexins and fear: implications for the treatment of anxiety disorders

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks